{"id":374579,"date":"2026-02-04T10:30:58","date_gmt":"2026-02-04T05:00:58","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=374579"},"modified":"2026-02-04T09:13:19","modified_gmt":"2026-02-04T03:43:19","slug":"cam-advises-mps-limited-unbound-medicine-acquisition","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/","title":{"rendered":"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on USD 16.5 Million Acquisition of Unbound Medicine"},"content":{"rendered":"
\n

Cyril Amarchand Mangaldas (“CAM<\/span>“) is acting as principal counsel to MPS Limited, a public limited company listed on Indian stock exchange and its subsidiary, MPS North America LLC (the “Purchaser<\/span>“), in relation to the acquisition of 100% of the issued and outstanding capital stock of Unbound Medicine, Inc. (the “Company”) pursuant to a stock purchase agreement executed among the Company, the Purchaser, William M. Detmer, and certain stockholders of the Company, for an aggregate consideration of USD16,500,000, subject to customary adjustments. The Company is engaged in the business of healthcare and medical information technology.<\/p>\n

The transaction was led by Mohit Gogia<\/span>, Partner; with support from Anisha Dash<\/span>, Senior Associate; and Muskaan Garg<\/span>, Swathi Kathi<\/span>, Avikalp Mishra<\/span>, and Yash Kataria<\/span>, Associates.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The transaction involves a 100% stock purchase and strengthens MPS’s global footprint in digital healthcare solutions.<\/p>\n","protected":false},"author":67533,"featured_media":374580,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[68835,30960,98109,98111,98107,98110,98108],"class_list":["post-374579","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-cam","tag-cyril-amarchand-mangaldas","tag-healthcare-technology-ma","tag-medical-information-technology-deal","tag-mps-limited","tag-stock-purchase-agreement","tag-unbound-medicine"],"yoast_head":"\nCyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on USD 16.5 Million Acquisition of Unbound Medicine | SCC Times<\/title>\n<meta name=\"description\" content=\"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on its USD 16.5 million acquisition of Unbound Medicine, Inc., a healthcare and medical information technology company, through a 100% stock purchase transaction\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on USD 16.5 Million Acquisition of Unbound Medicine\" \/>\n<meta property=\"og:description\" content=\"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on its USD 16.5 million acquisition of Unbound Medicine, Inc., a healthcare and medical information technology company, through a 100% stock purchase transaction\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-04T05:00:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/CAM-advises-MPS-Limited-Unbound-Medicine-Acquisition.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Rohit Patel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on USD 16.5 Million Acquisition of Unbound Medicine\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rohit Patel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/\",\"name\":\"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on USD 16.5 Million Acquisition of Unbound Medicine | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/CAM-advises-MPS-Limited-Unbound-Medicine-Acquisition.webp\",\"datePublished\":\"2026-02-04T05:00:58+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/9f9a9b419f6b27adf23cad92b93270f9\"},\"description\":\"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on its USD 16.5 million acquisition of Unbound Medicine, Inc., a healthcare and medical information technology company, through a 100% stock purchase transaction\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/CAM-advises-MPS-Limited-Unbound-Medicine-Acquisition.webp\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/CAM-advises-MPS-Limited-Unbound-Medicine-Acquisition.webp\",\"width\":886,\"height\":590,\"caption\":\"CAM advises MPS Limited Unbound Medicine Acquisition\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on USD 16.5 Million Acquisition of Unbound Medicine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/9f9a9b419f6b27adf23cad92b93270f9\",\"name\":\"Rohit Patel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e6f4de977176521a57d15bb15bafe88ddab843cb545559fc134d3da90f08857e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e6f4de977176521a57d15bb15bafe88ddab843cb545559fc134d3da90f08857e?s=96&d=mm&r=g\",\"caption\":\"Rohit Patel\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/rohitpatel\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on USD 16.5 Million Acquisition of Unbound Medicine | SCC Times","description":"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on its USD 16.5 million acquisition of Unbound Medicine, Inc., a healthcare and medical information technology company, through a 100% stock purchase transaction","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/","og_locale":"en_US","og_type":"article","og_title":"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on USD 16.5 Million Acquisition of Unbound Medicine","og_description":"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on its USD 16.5 million acquisition of Unbound Medicine, Inc., a healthcare and medical information technology company, through a 100% stock purchase transaction","og_url":"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2026-02-04T05:00:58+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/CAM-advises-MPS-Limited-Unbound-Medicine-Acquisition.jpg","type":"image\/jpeg"}],"author":"Rohit Patel","twitter_card":"summary_large_image","twitter_title":"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on USD 16.5 Million Acquisition of Unbound Medicine","twitter_misc":{"Written by":"Rohit Patel","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/","url":"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/","name":"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on USD 16.5 Million Acquisition of Unbound Medicine | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/CAM-advises-MPS-Limited-Unbound-Medicine-Acquisition.webp","datePublished":"2026-02-04T05:00:58+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/9f9a9b419f6b27adf23cad92b93270f9"},"description":"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on its USD 16.5 million acquisition of Unbound Medicine, Inc., a healthcare and medical information technology company, through a 100% stock purchase transaction","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/CAM-advises-MPS-Limited-Unbound-Medicine-Acquisition.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/CAM-advises-MPS-Limited-Unbound-Medicine-Acquisition.webp","width":886,"height":590,"caption":"CAM advises MPS Limited Unbound Medicine Acquisition"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/02\/04\/cam-advises-mps-limited-unbound-medicine-acquisition\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Cyril Amarchand Mangaldas is acting as principal counsel to MPS Limited on USD 16.5 Million Acquisition of Unbound Medicine"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/9f9a9b419f6b27adf23cad92b93270f9","name":"Rohit Patel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e6f4de977176521a57d15bb15bafe88ddab843cb545559fc134d3da90f08857e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e6f4de977176521a57d15bb15bafe88ddab843cb545559fc134d3da90f08857e?s=96&d=mm&r=g","caption":"Rohit Patel"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/rohitpatel\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/02\/CAM-advises-MPS-Limited-Unbound-Medicine-Acquisition.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":329063,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/08\/21\/cyril-amarchand-mangaldas-advises-kedaara-capital-and-partners-group-on-sale-of-controlling-stake-in-aavas-financiers-limited-to-cvc\/","url_meta":{"origin":374579,"position":0},"title":"Cyril Amarchand Mangaldas advises Kedaara Capital and Partners Group on Sale of Controlling Stake in Aavas Financiers Limited to CVC","author":"Bhumika Indulia","date":"August 21, 2024","format":false,"excerpt":"Cyril Amarchand Mangaldas (CAM) is advising Kedaara Capital and Partners Group in relation to their sale of controlling stake","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Kedaara Capital and Partners Group","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/08\/Kedaara-Capital-and-Partners-Group.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/08\/Kedaara-Capital-and-Partners-Group.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/08\/Kedaara-Capital-and-Partners-Group.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/08\/Kedaara-Capital-and-Partners-Group.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":377611,"url":"https:\/\/www.scconline.com\/blog\/post\/2026\/03\/07\/cyril-amarchand-mangaldas-advises-bessemer-sukino-healthcare-investment-2\/","url_meta":{"origin":374579,"position":1},"title":"Cyril Amarchand Mangaldas acted as legal counsel for Zenex Animal Health India Private Limited in connection with acquisition of majority stake in Netherlands based VievePharm","author":"Editor","date":"March 7, 2026","format":false,"excerpt":"The transaction involved a combination of primary investment and secondary acquisition from existing investors, including Stakeboat Capital, reflecting continued investor interest in India\u2019s healthcare services sector.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM Advises Bessemer Venture Partners","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/blog-45-18.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/blog-45-18.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/blog-45-18.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/blog-45-18.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":368166,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/","url_meta":{"origin":374579,"position":2},"title":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.","author":"Editor","date":"November 29, 2025","format":false,"excerpt":"Comprising a fresh issue and offer for sale by promoter shareholders. The IPO saw an exceptional overall subscription of 93.71 times, with QIB demand at 213.08 times.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM Sudeep Pharma IPO","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":329781,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/01\/cyril-amarchand-mangaldas-advises-vedanta-limited-on-the-sale-of-equity-shares-of-hindustan-zinc-limited-by-way-of-an-offer-for-sale-through-the-stock-exchange-mechanism\/","url_meta":{"origin":374579,"position":3},"title":"Cyril Amarchand Mangaldas advises Vedanta Limited on the sale of equity shares of Hindustan Zinc Limited by way of an offer for sale through the stock exchange mechanism","author":"Bhumika Indulia","date":"September 1, 2024","format":false,"excerpt":"Cyril Amarchand Mangaldas (CAM) advised Vedanta Limited (\u201cSeller\u201d) on the offer for sale of 63,605,891 equity shares of face value of Rs. 2 each","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Vedanta Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/blog-cyril-1.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/blog-cyril-1.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/blog-cyril-1.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/blog-cyril-1.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":331010,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/18\/cyril-amarchand-mangaldas-acts-as-legal-counsel-for-bajaj-housing-finance-limited-and-bajaj-finance-limited-on-the-ipo-of-equity-shares-of-the-company\/","url_meta":{"origin":374579,"position":4},"title":"Cyril Amarchand Mangaldas acts as legal counsel for Bajaj Housing Finance Limited and Bajaj Finance Limited on the IPO of equity shares of the Company","author":"Bhumika Indulia","date":"September 18, 2024","format":false,"excerpt":"Cyril Amarchand Mangaldas (CAM) acted as the Indian legal counsel to Bajaj Housing Finance Limited (the \u201cCompany\u201d) and Bajaj Finance Limited","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Bajaj Housing Finance Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/cyril-49.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/cyril-49.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/cyril-49.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/cyril-49.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":334623,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/07\/cyril-amarchand-mangaldas-advissd-himatsingka-siede-limited-as-their-legal-counsel\/","url_meta":{"origin":374579,"position":5},"title":"Cyril Amarchand Mangaldas advises Himatsingka Siede Limited as their legal counsel","author":"Bhumika Indulia","date":"November 7, 2024","format":false,"excerpt":"Cyril Amarchand Mangaldas (\u201cCAM\u201d) advised Himatsingka Siede Limited (the \u201cCompany\u201c) as their legal counsel as to Indian law","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Cyril Amarchand Mangaldas","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/11\/cyril-76.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/11\/cyril-76.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/11\/cyril-76.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/11\/cyril-76.webp?resize=700%2C400&ssl=1 2x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/374579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67533"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=374579"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/374579\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/374580"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=374579"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=374579"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=374579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}